Camurus AB (CHIX:CAMXS) 1-Year Share Buyback Ratio : -1.80% (As of Mar. 2025 )

View and export this data going back to 2016. Start your Free Trial

What is Camurus AB 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Camurus AB's current 1-Year Share Buyback Ratio was -1.80%.

CHIX:CAMXs's 1-Year Share Buyback Ratio is ranked better than
71.51% of 1183 companies
in the Biotechnology industry
Industry Median: -10.9 vs CHIX:CAMXs: -1.80

Competitive Comparison of Camurus AB's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Camurus AB's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Camurus AB 1-Year Share Buyback Ratio Calculation

Camurus AB's 1-Year Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Mar. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Mar. 2024 )
	=	(57.624	-	58.639)	/	57.624
	=	-1.8%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB (CHIX:CAMXs) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Camurus AB 1-Year Share Buyback Ratio Related Terms

Camurus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (CHIX:CAMXs) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

CAMRF:USA CAMX:Sweden 0RD1:UK 7CA:Germany

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines